Table 4.
Method | ACC | SEN | SPE | AUC | P-value |
---|---|---|---|---|---|
Baseline-SVM | 91.13±5.04 | 92.37 | 89.50 | 0.95 | <0.001 |
LASSO-SVM | 85.90±5.51 | 89.34 | 81.38 | 0.92 | <0.001 |
t-test-SVM | 79.60±6.93 | 84.31 | 73.38 | 0.86 | <0.001 |
Baseline-MK-SVM | 91.72±4.15 | 93.36 | 89.56 | 0.94 | 0.006 |
LASSO-MK-SVM | 86.82±4.57 | 89.57 | 82.66 | 0.90 | <0.001 |
t-test-MK-SVM | 90.06±4.35 | 92.75 | 86.50 | 0.93 | <0.001 |
Group Lasso-MK-SVM | 89.92±4.42 | 93.65 | 85.00 | 0.93 | <0.001 |
Euclid-MK-SVM | 91.72±4.15 | 93.36 | 89.56 | 0.94 | 0.006 |
Hypergraph-MK-SVM | 91.19±4.12 | 94.17 | 87.25 | 0.94 | <0.001 |
MFCC-MK-SVM | 93.72±3.38 | 95.17 | 91.81 | 0.95 | -- |
(b) LMCI versus NC | |||||
Method | ACC | SEN | SPE | AUC | P-value |
Baseline-SVM | 69.23±7.25 | 74.46 | 63.37 | 0.74 | <0.001 |
LASSO-SVM | 66.61±6.60 | 71.66 | 60.96 | 0.71 | <0.001 |
t-test-SVM | 62.81±6.12 | 70.38 | 54.28 | 0.65 | <0.001 |
Baseline-MK-SVM | 74.35±5.99 | 81.42 | 66.42 | 0.77 | <0.001 |
LASSO-MK-SVM | 71.46±6.00 | 76.86 | 62.72 | 0.71 | <0.001 |
t-test-MK-SVM | 73.00±5.76 | 81.52 | 63.42 | 0.75 | <0.001 |
Group Lasso-MK-SVM | 74.35±6.15 | 81.42 | 66.42 | 0.77 | <0.001 |
Euclid-MK-SVM | 74.35±5.99 | 81.42 | 66.42 | 0.77 | <0.001 |
Hypergraph-MK-SVM | 75.32±5.79 | 85.07 | 64.39 | 0.75 | <0.001 |
MFCC-MK-SVM | 78.47±5.61 | 85.88 | 70.16 | 0.78 | -- |
(c) EMCI versus LMCI | |||||
Method | ACC | SEN | SPE | AUC | P-value |
Baseline-SVM | 64.08±6.79 | 76.48 | 45.99 | 0.66 | <0.001 |
LASSO-SVM | 63.55±7.13 | 78.32 | 42.03 | 0.66 | <0.001 |
t-test-SVM | 63.32±5.35 | 87.33 | 28.29 | 0.64 | <0.001 |
Baseline-MK-SVM | 70.01±5.52 | 85.20 | 47.86 | 0.68 | <0.001 |
LASSO-MK-SVM | 68.43±4.83 | 88.92 | 37.31 | 0.66 | <0.001 |
t-test-MK-SVM | 69.10±5.25 | 85.05 | 45.83 | 0.66 | <0.001 |
Group Lasso-MK-SVM | 70.22±4.40 | 90.62 | 40.43 | 0.68 | <0.001 |
Euclid-MK-SVM | 70.01±5.52 | 85.20 | 47.86 | 0.68 | <0.001 |
Hypergraph-MK-SVM | 71.45±4.43 | 90.95 | 42.99 | 0.68 | 0.001 |
MFCC-MK-SVM | 73.87±4.77 | 90.55 | 49.52 | 0.70 | -- |